Premiums for public U.S. biopharma company trade sales 2010-2019

Published by
Matej Mikulic,
Jun 21, 2022
In 2019, the average premiums paid in public takeovers in the U.S. biopharma industry reached 97 percent, a significant increase from the 73 percent premiums paid the previous year. This statistic shows the average premiums paid in public U.S. biopharma company M&A deals from 2010 to 2019.

Average premiums paid in public U.S. biopharma M&A deals from 2010 to 2019*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2020

Region

United States

Survey time period

2010 to 2019

Supplementary notes

* Completed and announced (2019) trade sales of public U.S. biopharma companies with total deal value of at least $100 million. Non-weighted average premiums.
Premium means an increase of stock price on the day of deal announcement. Only deals with an upfront consideration of at least $100 million are included in this analysis. Given the high degree of variation in premiums paid, the average numbers should be interpreted with caution.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

International trade

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Research and development

6

Company rankings

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in IndiaGlobal pharmaceutical industryPharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical industry in South Korea
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu